Neutrophil to lymphocyte ratio (NLR) predicts pathological response to neoadjuvant immunochemotherapy in resectable esophageal cancer: a retrospective study.

Zhou Y, Guo Y, Cai X, Zhang Z, Zhang M

Open source

DOI
10.21037/jtd-2026-2105
Published
2026 Oct 30
Container
Journal of thoracic disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/jtd-2026-2105,
  title = {Neutrophil to lymphocyte ratio (NLR) predicts pathological response to neoadjuvant immunochemotherapy in resectable esophageal cancer: a retrospective study.},
  author = {Zhou Y and Guo Y and Cai X and Zhang Z and Zhang M},
  year = {2026},
  journal = {Journal of thoracic disease},
  doi = {10.21037/jtd-2026-2105},
  url = {https://doi.org/10.21037/jtd-2026-2105}
}

RIS

TY  - JOUR
TI  - Neutrophil to lymphocyte ratio (NLR) predicts pathological response to neoadjuvant immunochemotherapy in resectable esophageal cancer: a retrospective study.
AU  - Zhou Y
AU  - Guo Y
AU  - Cai X
AU  - Zhang Z
AU  - Zhang M
PY  - 2026
JO  - Journal of thoracic disease
DO  - 10.21037/jtd-2026-2105
UR  - https://doi.org/10.21037/jtd-2026-2105
ER  - 

APA

Y, Z., Y, G., X, C., Z, Z., & M, Z. (2026). Neutrophil to lymphocyte ratio (NLR) predicts pathological response to neoadjuvant immunochemotherapy in resectable esophageal cancer: a retrospective study.. Journal of thoracic disease. https://doi.org/10.21037/jtd-2026-2105

Source records